Acinetobacter baumannii : Emergence of a Successful Pathogen

10.1007/s10096-007-0371-8

10.3201/eid1101.040001

10.1128/AAC.45.2.583-588.2001

Alarcon, T., S. Lopez-Hernandez, D. Andreu, J. M. Saugar, L. Rivas, and M. Lopez-Brea. 2001. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains. Rev. Esp. Quimioter.14:184-190.

10.1016/j.jamcollsurg.2006.06.013

10.1016/0195-6701(87)90048-X

Al Shirawi, N., Z. A. Memish, A. Cherfan, and A. Al Shimemeri. 2006. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumanii treated with intrathecal colistin: case report and review of the literature. J. Chemother.18:554-558.

10.1128/JCM.40.2.685-686.2002

10.1093/clinids/14.1.83

10.1093/jac/dkl562

10.1128/AAC.44.4.1035-1040.2000

10.1128/JCM.38.1.40-43.2000

10.1128/JCM.43.2.903-905.2005

Audureau, A. 1940. Etude du genre Moraxella. Ann. Inst. Pasteur64:126-166.

10.1086/431488

10.1128/JB.00846-06

10.2174/187152607780090685

10.1128/JCM.43.9.4382-4390.2005

10.1086/319211

10.1128/jb.96.1.39-42.1968

10.1128/jb.95.5.1520-1541.1968

10.1067/mhl.2002.126103

10.1038/nature02241

Beijerinck, M. 1911. Pigmenten als oxydatieproducten gevormd door bacterien. Versl. Koninklijke Akad. Wetensch. Amsterdam19:1092-1103.

10.1093/jac/dkh289

Beno, P., V. Krcmery, and A. Demitrovicova. 2006. Bacteraemia in cancer patients caused by colistin-resistant gram-negative bacilli after previous exposure to ciprofloxacin and/or colistin. Clin. Microbiol. Infect.12:497-498.

10.1128/AAC.00035-06

10.1128/CMR.9.2.148

10.1097/00063198-200111000-00013

10.1093/ajhp/62.1.39

10.1007/s100960050254

10.1053/jhin.1999.0602

Bernards, A. T., L. Dijkshoorn, J. Van der Toorn, B. R. Bochner, and C. P. Van Boven. 1995. Phenotypic characterisation of Acinetobacter strains of 13 DNA-DNA hybridisation groups by means of the biolog system. J. Med. Microbiol.42:113-119.

Bernards, A. T., H. M. Frenay, B. T. Lim, W. D. Hendriks, L. Dijkshoorn, and C. P. van Boven. 1998. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii: an unexpected difference in epidemiologic behavior. Am. J. Infect. Control26:544-551.

10.1007/BF01695662

10.1128/AAC.00166-06

10.1128/AAC.46.3.892-895.2002

Betrosian, A. P., F. Frantzeskaki, A. Xanthaki, and G. Georgiadis. 2007. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. Scand. J. Infect. Dis.39:38-43.

10.1093/clinids/17.4.820

10.1007/s00134-003-1648-8

10.1016/S1074-5521(03)00026-7

10.1128/JCM.00796-06

10.1128/AAC.49.2.849-852.2005

10.1128/JCM.00089-07

10.1016/S0732-8893(00)00163-2

10.1093/jac/dkl345

10.1128/JCM.38.9.3299-3305.2000

10.1046/j.1469-0691.2000.00181.x

10.1128/AAC.44.2.428-432.2000

10.1128/AAC.44.6.1556-1561.2000

10.1099/00207713-36-2-228

10.1016/0769-2609(87)90042-1

10.1016/0923-2508(89)90021-1

10.1128/AAC.49.9.3903-3909.2005

Brauers, J., U. Frank, M. Kresken, A. C. Rodloff, and H. Seifert. 2005. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin. Microbiol. Infect.11:24-30.

10.1128/AAC.48.8.3127-3129.2004

10.1016/S0195-6701(03)00222-6

10.1080/00365540410027193

Brink, A., J. Moolman, M. C. da Silva, and M. Botha. 2007. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S. Afr. Med. J.97:273-279.

Brisou, J. 1953. Essay on the system of the genus Achromobacter. Ann. Inst. Pasteur (Paris)84:812-814.

Brisou, J., and A. R. Prevot. 1954. Studies on bacterial taxonomy. X. The revision of species under Achromobacter group. Ann. Inst. Pasteur (Paris)86:722-728.

10.1128/JCM.38.10.3636-3645.2000

10.1038/nm1276

10.1038/nrmicro1098

10.1093/jac/dki425

10.1111/j.1469-0691.2004.01016.x

Bukhary, Z., W. Mahmood, A. Al-Khani, and H. M. Al-Abdely. 2005. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi Med. J.26:656-658.

10.1016/j.bmcl.2003.12.037

Cameron, A. D., M. Ridderstrom, B. Olin, and B. Mannervik. 1999. Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue. Structure7:1067-1078.

10.1093/jac/dkl129

10.1016/j.jhin.2004.07.027

10.1099/ijs.0.02486-0

10.1053/jhin.1998.0535

10.1093/jac/39.2.255

CDC. 2004. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb. Mortal. Wkly. Rep.53:1063-1066.

10.1093/jac/dkl055

10.1038/nature05685

Chan, P. C., L. M. Huang, H. C. Lin, L. Y. Chang, M. L. Chen, C. Y. Lu, P. I. Lee, J. M. Chen, C. Y. Lee, H. J. Pan, J. T. Wang, S. C. Chang, and Y. C. Chen. 2007. Control of an outbreak of pandrug-resistant Acinetobacter baumannii colonization and infection in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol.28:423-429.

10.1128/JCM.43.4.1632-1639.2005

10.1016/0732-8893(95)00170-0

10.1016/0021-9681(87)90171-8

10.1128/AAC.48.10.4054-4055.2004

Chen, C. H., T. G. Young, and C. C. Huang. 2006. Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with bla(TEM-1), AmpC-type bla and integrase 1 genotypes. J. Microbiol. Immunol. Infect.39:372-379.

10.1111/j.1462-5822.2005.00538.x

10.3349/ymj.2006.47.1.63

10.1111/j.1469-0691.2004.00987.x

10.1111/j.1445-5994.2005.00925.x

10.1016/S1341-321X(06)70898-4

10.1128/AAC.45.3.710-714.2001

10.1099/jmm.0.46433-0

10.1128/JCM.37.9.2962-2967.1999

10.1371/journal.pbio.0030176

10.1093/clinids/22.6.1026

10.1093/jac/38.2.245

10.1021/jp064757

Clifford, H. E., and G. T. Stewart. 1961. Intraventricular administration of a new derivative of polymyxin B in meningitis due to Ps. pyocyanea. Lancetii:177-180.

Clinical and Laboratory Standards Institute. 2007. M7-A7. Dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI Wayne PA.

10.1128/AAC.50.2.756-758.2006

10.1128/JCM.00699-06

10.1128/AAC.33.10.1724

10.1016/j.ijantimicag.2005.02.013

10.1093/jac/42.6.793

10.1128/JCM.38.11.4086-4095.2000

10.1016/S0140-6736(98)05954-6

Corrigan, K. M., N. Y. Harmis, and M. D. Willcox. 2001. Association of Acinetobacter species with contact lens-induced adverse responses. Cornea20:463-466.

10.1093/jac/dkg407

10.1128/AAC.01132-06

10.1016/S0924-8579(99)00123-5

D'Agata, E. M., V. Thayer, and W. Schaffner. 2000. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect. Control Hosp. Epidemiol.21:588-591.

10.1128/JCM.41.7.3403-3406.2003

10.1093/jac/dkf092

10.1111/j.1469-0691.2006.01628.x

Da Silva, G. J., M. Correia, C. Vital, G. Ribeiro, J. C. Sousa, R. Leitao, L. Peixe, and A. Duarte. 2002. Molecular characterization of bla(IMP-5), a new integron-borne metallo-beta-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol. Lett.215:33-39.

10.1093/jac/dkh269

10.3201/1108.050103

DeBord, G. 1942. Descriptions of Mimeae trib. nov. with three genera and three species and two new species of Neisseria from conjunctivitis and vaginitis. Iowa State Coll. J. Sci.16:471-480.

DeBord, G. 1939. Organisms invalidating the diagnosis of gonorrhoeae by the smear method J. Bacteriol.38:119-120.

10.1016/j.chembiol.2006.02.010

10.1128/AAC.49.12.5172-5175.2005

10.1111/j.1469-0691.2005.01184.x

10.1016/j.jhin.2003.10.017

10.1073/pnas.0608657104

10.1128/jcm.34.6.1519-1525.1996

10.1128/jcm.31.3.702-705.1993

10.1128/AAC.48.12.4919-4921.2004

10.1111/j.1469-0691.2005.01093.x

10.1016/S0723-2020(98)80006-4

Dobrewski, R., E. Savov, A. T. Bernards, M. van den Barselaar, P. Nordmann, P. J. van den Broek, and L. Dijkshoorn. 2006. Genotypic diversity and antibiotic susceptibility of Acinetobacter baumannii isolates in a Bulgarian hospital. Clin. Microbiol. Infect.12:1135-1137.

10.1128/AAC.00560-07

10.1086/521246

10.1128/jcm.33.5.1108-1113.1995

10.1128/AAC.44.1.196-199.2000

10.1128/JCM.42.4.1542-1546.2004

10.1073/pnas.0702403104

10.1128/JCM.41.9.4188-4193.2003

10.1128/AEM.68.12.6353-6360.2002

10.1099/mic.0.27371-0

10.1128/JCM.01535-06

Drago, L., E. De Vecchi, L. Nicola, A. Colombo, A. Guerra, and M. R. Gismondo. 2004. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp. Chemotherapy50:202-210.

10.1016/j.ijantimicag.2003.09.026

10.1021/pr050143q

Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, Jr., and M. N. Swartz. 1993. Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med.328:21-28.

Dy, M. E., J. A. Nord, V. J. LaBombardi, and J. W. Kislak. 1999. The emergence of resistant strains of Acinetobacter baumannii: clinical and infection control implications. Infect. Control Hosp. Epidemiol.20:565-567.

10.1128/jb.174.23.7670-7679.1992

10.1128/JCM.00619-06

10.1128/jcm.34.10.2414-2420.1996

10.1086/431675

10.1128/AAC.01139-06

Endimiani, A., F. Luzzaro, A. Tamborini, G. Lombardi, V. Elia, R. Belloni, and A. Toniolo. 2002. Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix automated microbiology system. New Microbiol.25:323-329.

10.1128/JCM.38.3.1008-1015.2000

Ermertcan, S., M. Hosgor, O. Tunger, and G. Cosar. 2001. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections. Scand. J. Infect. Dis.33:818-821.

10.1099/jmm.0.46823-0

10.1016/j.ijantimicag.2006.12.012

10.1186/cc4869

Falagas, M. E., I. A. Bliziotis, and V. H. Tam. 2007. Intraventricular or intrathecal use of polymyxins in patients with gram-negative meningitis: a systematic review of the available evidence. Int. J. Antimicrob. Agents29:9-25.

10.1086/429323

10.1128/AAC.00101-06

10.1007/s10096-006-0191-2

10.1093/jac/dkl130

Falagas, M. E., P. Kopterides, and I. I. Siempos. 2006. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin. Infect. Dis.43:389.

10.1111/j.1469-0691.2006.01559.x

10.1186/1471-2334-5-1

Feeley, T. W., G. C. Du Moulin, J. Hedley-Whyte, L. S. Bushnell, J. P. Gilbert, and D. S. Feingold. 1975. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med.293:471-475.

10.1093/genetics/154.4.1439

10.1093/jac/dkg097

10.1086/517243

Fetiye, K., A. Karadenizli, E. Okay, S. Oz, F. Budak, S. Gundes, and H. Vahaboglu. 2004. Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection. Ann. Clin. Microbiol. Antimicrob.3:2.

Flanagan, A. D. 1971. Adverse effects of sodium colistimethate. Ann. Intern. Med.74:143-144.

10.1128/AAC.49.4.1636-1638.2005

Foulds, G. 1986. Pharmacokinetics of sulbactam/ampicillin in humans: a review. Rev. Infect. Dis.8(Suppl. 5):S503-S511.

10.1086/500202

10.1371/journal.pgen.0020007

Francey, T., F. Gaschen, J. Nicolet, and A. P. Burnens. 2000. The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. J. Vet. Intern. Med.14:177-183.

10.1128/JCM.00879-06

10.1111/j.1469-0691.2005.01271.x

10.1128/JCM.42.4.1466-1470.2004

10.1111/j.1469-0691.2005.01351.x

10.1128/JCM.39.1.183-190.2001

10.1016/S0732-8893(02)00500-X

Gant, V. A., M. W. Wren, M. S. Rollins, A. Jeanes, S. S. Hickok, and T. J. Hall. 2007. Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms. J. Antimicrob. Chemother.60:294-299.

10.1097/00003246-199909000-00015

Garcia-Penuela, E., E. Aznar, T. Alarcon, and M. Lopez-Brea. 2006. Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong. Rev. Esp. Quimioter.19:45-50.

10.1097/01.CCM.0000089936.09573.F3

10.1007/s00134-005-2598-0

10.1086/374337

Gaur, A., P. Prakash, S. Anupurba, and T. M. Mohapatra. 2007. Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multidrug-resistant Acinetobacter baumannii isolated from nosocomial infections. Int. J. Antimicrob. Agents29:446-450.

10.1086/432803

10.1159/000238887

10.1128/jcm.30.10.2680-2685.1992

10.1111/j.1699-0463.1993.tb00187.x

10.1128/jcm.29.2.277-282.1991

10.1093/jac/46.5.807

10.1016/j.peptides.2003.08.003

10.1016/S0732-8893(01)00258-9

Gilad, J., M. Giladi, F. Poch, Y. Aharoni, and D. Schwartz. 2006. “All-in-one-plate” E-test and disk diffusion susceptibility co-testing for multiresistant Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis.25:799-802.

10.1089/mdr.2006.9995

10.1086/338786

10.1086/508360

Glew, R. H., R. C. Moellering, Jr., and L. J. Kunz. 1977. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine (Baltimore)56:79-97.

10.1016/S0140-6736(94)90694-7

10.1186/1471-2180-1-16

10.1128/MMBR.00002-06

10.1016/S0944-5013(01)80004-5

Gospodarek, E., A. Grzanka, Z. Dudziak, and J. Domaniewski. 1998. Electron-microscopic observation of adherence of Acinetobacter baumannii to red blood cells. Acta Microbiol. Pol.47:213-217.

Gottlieb, T., and D. J. Barnes. 1989. Community-acquired Acinetobacter pneumonia. Aust. N. Z. J. Med.19:259-260.

10.1128/jcm.30.6.1588-1591.1992

Goverman, J., J. M. Weber, T. J. Keaney, and R. L. Sheridan. 2007. Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J. Burn Care Res.28:421-426.

10.1128/jcm.31.9.2417-2420.1993

Gribun, A., Y. Nitzan, I. Pechatnikov, G. Hershkovits, and D. J. Katcoff. 2003. Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii. Curr. Microbiol.47:434-443.

10.1086/506596

Griffith, M. E., M. W. Ellis, and C. K. Murray. 2006. Acinetobacter nares colonization of healthy US soldiers. Infect. Control Hosp. Epidemiol.27:787-788.

Griffith, M. E., D. R. Lazarus, P. B. Mann, J. A. Boger, D. R. Hospenthal, and C. K. Murray. 2007. Acinetobacter skin carriage among US army soldiers deployed in Iraq. Infect. Control Hosp. Epidemiol.28:720-722.

10.1128/JCM.00407-06

10.1128/jcm.35.12.3071-3077.1997

Grupper, M., H. Sprecher, T. Mashiach, and R. Finkelstein. 2007. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect. Control Hosp. Epidemiol.28:293-298.

10.1128/JCM.01318-06

10.1099/0022-1317-49-10-929

Halstead, D. C., J. Abid, and M. J. Dowzicky. 2007. Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial. J. Infect.55:49-57.

10.1164/ajrccm.162.1.9910071

10.1093/jac/dkh368

Hartstein, A. I., V. H. Morthland, J. W. Rourke, Jr., J. Freeman, S. Garber, R. Sykes, and A. L. Rashad. 1990. Plasmid DNA fingerprinting of Acinetobacter calcoaceticus subspecies anitratus from intubated and mechanically ventilated patients. Infect. Control Hosp. Epidemiol.11:531-538.

10.1046/j.1432-1327.1998.2510189.x

10.1128/AEM.02979-05

10.1128/AAC.00858-06

Hayes, E. R., and E. Yow. 1950. Meningitis due to Pseudomonas aeruginosa treated with polymyxin B. Am. J. Med. Sci.220:633-637.

10.1128/JCM.43.1.199-207.2005

10.1128/AAC.44.8.2211-2213.2000

10.1128/br.37.4.522-561.1973

10.1093/jac/49.3.479

10.1128/AAC.47.1.268-273.2003

10.1128/AAC.49.10.4174-4179.2005

10.1128/AAC.49.8.3198-3202.2005

10.1111/j.1469-0691.2005.01320.x

10.1111/j.1469-0691.2007.01819.x

10.1128/AAC.48.5.1586-1592.2004

10.1093/jac/dkh427

Hoban, D. J., S. K. Bouchillon, and M. J. Dowzicky. 2007. Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Diagn. Microbiol. Infect. Dis.57:423-428.

10.1093/jac/dkh470

10.1093/jac/41.4.494

10.1016/j.jcf.2005.05.018

Holloway, K. P., N. G. Rouphael, J. B. Wells, M. D. King, and H. M. Blumberg. 2006. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit. Ann. Pharmacother.40:1939-1945.

Hope, R., T. Parsons, S. Mushtaq, D. James, and D. M. Livermore. 2007. Determination of disc breakpoints and evaluation of Etests for tigecycline susceptibility testing by the BSAC method. J. Antimicrob. Chemother.60:770-774.

10.1093/jac/dki386

10.1128/jcm.33.6.1567-1572.1995

Houang, E. T., Y. W. Chu, C. M. Leung, K. Y. Chu, J. Berlau, K. C. Ng, and A. F. Cheng. 2001. Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J. Clin. Microbiol.39:228-234.

10.1128/AAC.47.4.1382-1390.2003

Huang, Y. C., L. H. Su, T. L. Wu, H. S. Leu, W. S. Hsieh, T. M. Chang, and T. Y. Lin. 2002. Outbreak of Acinetobacter baumannii bacteremia in a neonatal intensive care unit: clinical implications and genotyping analysis. Pediatr. Infect. Dis. J.21:1105-1109.

Huang, Z. M., P. H. Mao, Y. Chen, L. Wu, and J. Wu. 2004. Study on the molecular epidemiology of SHV type beta-lactamase-encoding genes of multiple-drug-resistant Acinetobacter baumannii. Zhonghua Liu Xing Bing Xue Za Zhi25:425-427.

10.1128/AAC.49.7.2941-2948.2005

10.1128/AAC.00778-06

10.1378/chest.115.5.1378

10.1099/jmm.0.45986-0

10.1378/chest.118.1.146

Iredell, J., L. Thomas, D. Power, and E. Mendes. 2007. Tigecycline resistance in Australian antibiotic-resistant gram-negative bacteria. J. Antimicrob. Chemother.59:816-818.

Iregbu, K. C., F. T. Ogunsola, and T. O. Odugbemi. 2002. Infections caused by Acinetobacter species and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos. West Afr. J. Med.21:226-229.

10.1099/13500872-142-7-1881

Janssen, P., and L. Dijkshoorn. 1996. High resolution DNA fingerprinting of Acinetobacter outbreak strains. FEMS Microbiol. Lett.142:191-194.

10.1099/00207713-47-4-1179

10.1128/AAC.49.4.1337-1339.2005

10.1128/jcm.32.10.2353-2358.1994

Jawad, A., J. Heritage, A. M. Snelling, D. M. Gascoyne-Binzi, and P. M. Hawkey. 1996. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J. Clin. Microbiol.34:2881-2887.

10.1128/JCM.36.7.1938-1941.1998

10.1592/phco.21.2.142.34114

10.1128/JCM.43.5.2241-2245.2005

Jeong, S. H., I. K. Bae, K. O. Park, Y. J. An, S. G. Sohn, S. J. Jang, K. H. Sung, K. S. Yang, K. Lee, D. Young, and S. H. Lee. 2006. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J. Microbiol.44:423-431.

10.1016/j.jhin.2005.07.007

10.1007/s100960000400

10.1093/clinids/24.5.932

10.1007/s10096-001-0680-2

10.1086/520029

10.1111/j.1469-0691.2005.01227.x

Joly-Guillou, M. L., D. Decre, J. L. Herrman, E. Bourdelier, and E. Bergogne-Berezin. 1995. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. J. Antimicrob. Chemother.36:619-629.

10.1093/jac/46.5.827

10.1016/S1473-3099(06)70471-6

Jones, M. E. 2007. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect.13(Suppl. 2):17-24.

10.1128/JCM.43.2.925-927.2005

10.1016/j.diagmicrobio.2004.03.016

10.1128/JCM.01588-06

10.1128/JCM.39.9.3247-3253.2001

10.1128/AAC.48.3.1055-1057.2004

10.1128/jb.112.2.917-931.1972

Kaatz, G. W. 2005. Bacterial efflux pump inhibition. Curr. Opin. Investig. Drugs6:191-198.

10.1016/j.ijantimicag.2006.07.008

10.1080/00365540500452499

10.1089/mdr.2005.11.287

10.1016/j.jinf.2004.05.008

Kau, H. C., C. C. Tsai, S. C. Kao, W. M. Hsu, and J. H. Liu. 2002. Corneal ulcer of the side port after phacoemulsification induced by Acinetobacter baumannii. J. Cataract Refract. Surg.28:895-897.

10.1086/502550

10.1016/j.diagmicrobio.2005.03.003

10.1128/JCM.02486-06

10.1128/JB.181.13.4133-4136.1999

10.1164/rccm.200505-730OC

10.1093/jac/dkm305

10.1093/jac/dkh080

10.1128/JCM.36.9.2522-2529.1998

10.1128/JCM.39.1.8-13.2001

10.1086/501901

10.1093/jac/dkl544

10.1378/chest.115.2.462

Komura, S., and K. Kurahashi. 1979. Partial purification and properties of l-2,4-diaminobutyric acid activating enzyme from a polymyxin E producing organism. J. Biochem. (Tokyo)86:1013-1021.

10.1016/j.ijid.2006.09.011

10.1128/AAC.01433-06

10.1111/j.1469-0691.2006.01601.x

10.1177/0091270003257225

10.1086/432583

10.1093/jac/dkl499

10.1093/jac/dki153

10.1093/jac/dkm129

10.1001/archinte.162.13.1515

10.1128/JCM.44.3.827-832.2006

10.3201/eid1009.040242

Bergey's manual of determinative bacteriology. 1974

10.1021/jm050113z

10.1016/j.diagmicrobio.2006.05.002

10.1016/j.resmic.2005.09.011

Lee, K., W. G. Lee, Y. Uh, G. Y. Ha, J. Cho, and Y. Chong. 2003. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. andAcinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9:868-871.

10.3349/ymj.2006.47.5.634

Lee, K., Y. S. Lim, D. Yong, J. H. Yum, and Y. Chong. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. andAcinetobacter spp. J. Clin. Microbiol. 41:4623-4629.

Lee, K., D. Yong, J. H. Yum, Y. S. Lim, A. Bolmstrom, A. Qwarnstrom, A. Karlsson, and Y. Chong. 2005. Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. andAcinetobacter spp. J. Clin. Microbiol. 43:942-944.

10.1128/AAC.49.11.4485-4491.2005

10.1128/AAC.48.1.224-228.2004

LeGall, J. R., P. Loirat, and A. Alperovitch. 1986. APACHE II—a severity of disease classification system. Crit. Care Med.14:754-755.

Lemoigne, M., H. Girard, and G. Jacobelli. 1952. Soil bacteria easily utilizing 2-3,butanediol. Ann. Inst. Pasteur (Paris)82:389-398.

Lessel, E. F. 1971. Subcommittee on nomenclature of Moraxella and allied bacteria. Int. J. Syst. Bacteriol.21:213-214.

10.1378/chest.129.1.102

10.1046/j.1469-0691.2002.00415.x

10.1086/514732

10.1016/S0924-8579(02)00276-5

Levy, J., T. Oshry, R. Rabinowitz, and T. Lifshitz. 2005. Acinetobacter corneal graft ulcer and endophthalmitis: report of two cases. Can. J. Ophthalmol.40:79-82.

10.1177/0091270006291035

10.1128/AAC.00756-06

10.1016/S1473-3099(06)70580-1

10.1128/AAC.49.11.4814-4815.2005

10.1128/AAC.00103-06

10.1128/JCM.01573-06

10.1128/JCM.40.12.4776-4778.2002

Lin, S. Y., W. W. Wong, C. P. Fung, C. E. Liu, and C. Y. Liu. 1998. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases. J. Microbiol. Immunol. Infect.31:119-124.

Lindbohm, N., J. A. Moilanen, M. H. Vesaluoma, and T. M. Tervo. 2005. Acinetobacter and Staphylococcus aureus ulcerative keratitis after laser in situ keratomileusis treated with antibiotics and phototherapeutic keratectomy. J. Refract. Surg.21:404-406.

Linden, P. K., and D. L. Paterson. 2006. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin. Infect. Dis.43(Suppl. 2):S89-S94.

10.1086/510590

Loh, L. C., C. T. Yii, K. K. Lai, S. P. Seevaunnamtum, G. Pushparasah, and J. M. Tong. 2006. Acinetobacter baumannii respiratory isolates in ventilated patients are associated with prolonged hospital stay. Clin. Microbiol. Infect.12:597-598.

10.1128/AAC.00116-06

10.1016/j.bcp.2005.12.008

10.1128/JCM.40.12.4741-4743.2002

10.1093/clinids/20.4.790

10.1128/AAC.01406-06

10.1128/AAC.45.12.3375-3380.2001

Mahgoub, S., J. Ahmed, and A. E. Glatt. 2002. Completely resistant Acinetobacter baumannii strains. Infect. Control Hosp. Epidemiol.23:477-479.

10.1073/pnas.95.6.3140

Malfroot, A., G. Adam, O. Ciofu, G. Doring, C. Knoop, A. B. Lang, P. Van Damme, I. Dab, and A. Bush. 2005. Immunisation in the current management of cystic fibrosis patients. J. Cyst. Fibros.4:77-87.

10.1086/313902

Mannheim, W., and W. Stenzel. 1962. Zur Systematik der obligat aeroben gram-negativen Diplobakterien des Menschen. Zentralbl. Bakteriol.198:55-83.

10.1001/jama.292.24.3006

Marais, E., G. de Jong, V. Ferraz, B. Maloba, and A. G. Duse. 2004. Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa. Am. J. Infect. Control32:278-281.

10.1128/JCM.02424-06

10.1128/AAC.48.9.3298-3304.2004

Markou, N., H. Apostolakos, C. Koumoudiou, M. Athanasiou, A. Koutsoukou, I. Alamanos, and L. Gregorakos. 2003. Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit. Care7:R78-R83.

Marque, S., L. Poirel, C. Heritier, S. Brisse, M. D. Blasco, R. Filip, G. Coman, T. Naas, and P. Nordmann. 2005. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J. Clin. Microbiol.43:4885-4888.

10.1086/502489

McDonald, L. C., S. N. Banerjee, W. R. Jarvis, et al. 1999. Seasonal variation of Acinetobacter infections: 1987-1996. Clin. Infect. Dis.29:1133-1137.

Menon, T., S. Shanmugasundaram, B. Nandhakumar, K. Nalina, and Balasubramaniam. 2006. Infective endocarditis due to Acinetobacter baumannii complex—a case report. Indian J. Pathol. Microbiol.49:576-578.

10.1128/JCM.00614-06

10.1093/jac/dkm181

Metan, G., E. Alp, B. Aygen, and B. Sumerkan. 2007. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. Int. J. Antimicrob. Agents29:112-113.

10.7326/0003-4819-119-5-199309010-00001

10.1128/AAC.35.10.2098

Michalopoulos, A., S. K. Kasiakou, Z. Mastora, K. Rellos, A. M. Kapaskelis, and M. E. Falagas. 2005. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Crit. Care9:R53-R59.

10.1080/00365540410020776-1

10.1111/j.1469-0691.2004.01043.x

Reference deleted.

Reference deleted.

10.1128/AAC.46.6.1946-1952.2002

10.1093/jac/dkh485

10.1016/j.jinf.2005.11.019

10.1128/AAC.00665-06

10.7205/MILMED.171.9.826

10.1016/0195-6701(90)90029-N

10.1128/AAC.48.4.1313-1319.2004

10.1093/jac/dkm150

10.1128/AAC.49.4.1432-1440.2005

10.1093/jac/dkl178

10.3201/eid1708.051547

10.3201/eid1304.060755

10.1128/JCM.43.9.4826-4829.2005

10.1016/j.ijantimicag.2006.08.032

10.1128/JCM.42.9.3978-3984.2004

10.1128/JCM.43.9.4862-4864.2005

National Institutes of Health. 2006. Partnerships to improve diagnosis and treatment of selected drug-resistant healthcare-associated infections (U01). RFA-AI-06-036. National Institutes of Health Bethesda MD.

10.1093/jac/dkm018

Neely, A. N., M. P. Maley, and G. D. Warden. 1999. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin. Infect. Dis.29:1358-1360.

Nejjari, N., F. Zerhouni, A. Bouharrou, A. Habzi, T. Najdi, M. Lahbabi, and S. Benomar. 2003. Nosocomial infections caused by Acinetobacter: experience in a neonatal care unit in Casablanca. Tunis Med.81:121-125.

10.1099/00207713-51-5-1891

10.1099/ijs.0.02631-0

10.1099/jmm.0.05445-0

10.1099/jmm.0.45716-0

10.1099/00222615-48-3-287

10.1093/jac/dkm231

10.1093/jac/dkl347

10.1227/00006123-199411000-00008

10.1128/jb.143.2.872-878.1980

10.1099/00207713-38-2-209

10.1128/JCM.42.11.5256-5263.2004

Noguchi, J. K., and M. A. Gill. 1988. Sulbactam: a beta-lactamase inhibitor. Clin. Pharm.7:37-51.

10.1080/00365549850160774

Obana, Y., and T. Nishino. 1990. In-vitro and in-vivo activities of sulbactam and YTR830H against Acinetobacter calcoaceticus. J. Antimicrob. Chemother.26:677-682.

10.1093/jac/28.6.791

Olut, A. I., and E. Erkek. 2005. Early prosthetic valve endocarditis due to Acinetobacter baumannii: a case report and brief review of the literature. Scand. J. Infect. Dis.37:919-921.

O'Neill, E., H. Humphreys, J. Phillips, and E. G. Smyth. 2006. Third-generation cephalosporin resistance among gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy. J. Antimicrob. Chemother.57:356-359.

10.1128/AAC.47.8.2659-2662.2003

Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother. abstr. A-11. 2004

10.1093/jac/dkl512

10.1093/jac/dkl303

10.1128/AAC.48.11.4479-4481.2004

Palabiyikoglu, I., E. Tekeli, F. Cokca, O. Akan, N. Unal, I. Erberktas, S. Lale, and S. Kiraz. 2006. Nosocomial meningitis in a university hospital between 1993 and 2002. J. Hosp. Infect.62:94-97.

10.1016/j.ijantimicag.2006.09.009

Paramythiotou, E., D. Karakitsos, H. Aggelopoulou, P. Sioutos, G. Samonis, and A. Karabinis. 2007. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med. Mal. Infect.37:124-125.

10.1128/AAC.00284-06

10.1016/0924-8579(93)90045-7

10.1016/j.jhin.2005.01.007

10.1128/AAC.01198-06

10.1093/jac/dkl036

10.1086/507012

10.1128/AAC.50.1.399-400.2006

10.1093/jac/dkl441

Pereira, G. H., P. R. Muller, and A. S. Levin. 2007. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant gram-negative bacilli with inhaled polymyxin B. Diagn. Microbiol. Infect. Dis.58:235-240.

10.1128/AAC.01464-06

10.1128/AAC.40.3.715

10.1097/01.sla.0000251707.32332.c1

10.1128/AAC.49.9.3910-3918.2005

10.1128/AAC.43.4.738

10.1128/AAC.31.2.230

10.1111/j.1469-0691.2005.01198.x

10.1128/CMR.19.2.382-402.2006

Piechaud, D., M. Piechaud, and L. Second. 1951. Etude de 26 souches de Moraxella iwoffi. Ann. Inst. Pasteur80:97-99.

Pimentel, J. D., J. Low, K. Styles, O. C. Harris, A. Hughes, and E. Athan. 2005. Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward. J. Hosp. Infect.59:249-253.

Plachouras, D., E. J. Giamarellos-Bourboulis, N. Kentepozidis, F. Baziaka, V. Karagianni, and H. Giamarellou. 2007. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis.57:419-422.

10.1016/j.jhin.2006.11.010

10.1128/AAC.49.5.1708-1713.2005

Poirel, L., A. Karim, A. Mercat, I. Le Thomas, H. Vahaboglu, C. Richard, and P. Nordmann. 1999. Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother.43:157-158.

10.1111/j.1469-0691.2006.01537.x

10.1128/AAC.49.1.202-208.2005

10.1128/JCM.41.8.3542-3547.2003

10.1111/j.1469-0691.2006.01456.x

10.1128/AAC.50.4.1442-1448.2006

10.1093/jac/dkl004

10.1086/375821

10.1128/CMR.00001-07

10.1038/nbt1309

Rahal, J. J. 2006. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Clin. Infect. Dis.43(Suppl. 2):S95-S99.

10.1001/jama.280.14.1233

10.1007/s00134-005-2691-4

Reis, A. O., D. A. Luz, M. C. Tognim, H. S. Sader, and A. C. Gales. 2003. Polymyxin-resistant Acinetobacter spp. isolates: what is next? Emerg. Infect. Dis.9:1025-1027.

10.1016/j.diagmicrobio.2005.10.010

10.1016/j.diagmicrobio.2006.07.009

10.1093/jac/dkg344

10.1093/jac/49.4.697

10.1128/AAC.47.7.2310-2312.2003

10.1128/AAC.44.5.1229-1235.2000

10.1086/504487

Riley, T. V., S. A. Webb, H. Cadwallader, B. D. Briggs, L. Christiansen, and R. A. Bowman. 1996. Outbreak of gentamicin-resistant Acinetobacter baumanii in an intensive care unit: clinical, epidemiological and microbiological features. Pathology28:359-363.

Rizos, I., S. Tsiodras, S. Papathanasiou, A. Rigopoulos, J. Barbetseas, and C. Stefanadis. 2007. Prosthetic valve endocarditis due to Acinetobacter spp: a rare case and literature review. Am. J. Med. Sci.333:197-199.

10.1016/j.jhin.2006.06.025

10.1016/S0213-005X(03)72930-9

10.1093/jac/47.4.479

10.1111/j.1469-0691.2004.00910.x

Rossau, R., A. van Landschoot., M. Gillis, and J. de Ley. 1991. Taxonomy of Moraxellaceae fam. nov., a new bacterial family to accomodate the genera Moraxella,Acinetobacter, and Psychrobacter and related organisms. Int. J. Syst. Bacteriol.41:310-319.

Roussel-Delvallez, M., F. Wallet, F. Delpierre, and R. J. Courcol. 1996. In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii. J. Chemother.8:365-368.

10.1111/j.1574-6968.2007.00828.x

10.1093/jac/dkm058

10.1093/jac/dkl274

10.1016/j.ijantimicag.2004.08.013

10.1016/j.ijantimicag.2005.01.011

10.1016/j.diagmicrobio.2005.05.005

10.1179/joc.2005.17.6.622

Samuel, S. O., A. Fadeyi, A. A. Akanbi II, N. B. Ameen, C. Nwabuisi, and B. A. Onile. 2006. Bacterial isolates of blood cultures in patients with suspected septicaemia in Ilorin, Nigeria. Afr. J. Med. Med. Sci.35:137-141.

10.1007/s10096-007-0330-4

10.1073/pnas.0607557104

Santos Filho, L., K. J. Eagye, J. L. Kuti, and D. P. Nicolau. 2007. Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy. Clin. Microbiol. Infect.13:579-585.

10.1128/AAC.46.3.875-878.2002

10.1128/AAC.50.4.1251-1256.2006

10.1016/S0924-8579(02)00207-8

10.1093/jac/36.3.585

10.2307/30140949

10.1592/phco.27.7.980

10.1128/jb.56.4.379-385.1948

10.1128/AAC.01099-06

10.1021/bi034672o

10.1016/j.jhin.2005.05.009

10.1086/518170

10.1093/jac/dki265

10.1016/j.femsle.2005.01.005

10.1128/AAC.48.2.612-614.2004

10.1016/S0934-8840(11)80427-5

10.2307/30148402

10.1128/jcm.35.11.2819-2825.1997

Seifert H. L. Dijkshoorn J. Gielen A. Nemec K. Osterhage M. Erhard and O. Krut. 2007. Abstr. 107th Gen. Meet. Am. Soc. Microbiol. abstr. C-172. American Society for Microbiology Washington DC.

10.1128/JCM.43.9.4328-4335.2005

10.1128/jcm.33.5.1402-1407.1995

10.1128/jcm.32.1.82-86.1994

10.1093/jac/dkl383

10.1097/00005792-199511000-00004

10.1007/BF01715492

10.1099/00222615-47-5-455

10.1111/j.1469-0691.1998.tb00052.x

Shankar, R., L. K. He, A. Szilagyi, K. Muthu, R. L. Gamelli, M. Filutowicz, J. L. Wendt, H. Suzuki, and M. Dominguez. 2007. A novel antibacterial gene transfer treatment for multidrug-resistant Acinetobacter baumannii-induced burn sepsis. J. Burn Care Res.28:6-12.

10.1128/JCM.41.12.5407-5413.2003

10.1093/clinids/17.5.843

10.1086/502307

10.1086/502046

10.1021/pr060372s

10.1128/AAC.49.12.4876-4883.2005

10.1099/00207713-30-1-225

Smith, A. W., and K. E. Alpar. 1991. Immune response to Acinetobacter calcoaceticus infection in man. J. Med. Microbiol.34:83-88.

10.1101/gad.1510307

10.1016/S0195-6701(03)00046-X

10.1128/jcm.34.5.1193-1202.1996

10.1093/jac/dkh369

Song, J. Y., S. Y. Kee, I. S. Hwang, Y. B. Seo, H. W. Jeong, W. J. Kim, and H. J. Cheong. 2007. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother.60:317-322.

10.1086/420937

10.1097/01.crd.0000163801.67781.a2

10.1007/s10096-003-0962-y

Stephens, C., S. J. Francis, V. Abell, J. R. DiPersio, and P. Wells. 2007. Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital. Am. J. Infect. Control35:212-215.

10.1128/JCM.41.1.351-358.2003

10.1146/annurev.bi.46.070177.003451

10.1128/AAC.49.10.4362-4364.2005

10.1080/02688690500080729

10.1016/S0195-6701(99)90424-3

10.3201/eid1301.060716

10.1128/JCM.42.11.5102-5108.2004

10.1128/JCM.38.2.526-529.2000

10.1086/499819

10.1128/AAC.49.12.4920-4927.2005

10.1093/jac/dkl330

10.1016/j.diagmicrobio.2007.02.008

10.1093/jac/dkm178

10.1111/j.1469-0691.2007.01708.x

10.1093/jac/42.2.270

Thamlikitkul, V., S. Tiengrim, and C. Tribuddharat. 2007. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother.60:177-178.

10.1053/jhin.2000.0851

Tien, H. C., A. Battad, E. A. Bryce, J. Fuller, M. Mulvey, K. Bernard, R. Brisebois, J. J. Doucet, S. B. Rizoli, R. Fowler, and A. Simor. 2007. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect. Dis.7:95.

10.1016/j.ijantimicag.2005.10.012

10.1111/j.1699-0463.1989.tb00449.x

10.1016/j.ijid.2003.11.009

10.1086/504356

10.1099/mic.0.26541-0

Tomlin, C. E. 1951. Pseudomonas meningitis; report of a case with recovery after polymyxin B therapy. AMA Arch. Intern. Med.87:863-867.

Toney, J. H. 2003. Metallo-beta-lactamase inhibitors: could they give old antibacterials new life? Curr. Opin. Investig. Drugs4:115-116.

Tong, W., R. Wang, D. Chai, Z. Li, and F. Pei. 2006. In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp. Int. J. Antimicrob. Agents28:454-456.

Trottier, V., P. G. Segura, N. Namias, D. King, L. R. Pizano, and C. I. Schulman. 2007. Outcomes of Acinetobacter baumannii infection in critically ill burned patients. J. Burn Care Res.28:248-254.

10.1093/jac/dkl365

10.3201/eid1206.051097

10.1128/JCM.38.9.3505-3507.2000

10.1086/425368

10.1128/CMR.00047-06

10.1128/JCM.00547-06

10.1128/JCM.43.7.3074-3082.2005

10.1016/j.jhin.2004.05.011

10.1111/j.1574-6968.2006.00195.x

10.1128/JCM.01021-06

10.1016/j.diagmicrobio.2005.10.002

10.1093/infdis/167.2.448

10.1128/AAC.45.3.994-995.2001

10.1086/374847

10.1093/jac/dkl273

10.1128/AAC.41.10.2265

10.1128/JCM.01971-06

Valero, C., M. C. Farinas, D. Garcia Palomo, J. C. Mazarrasa, and J. Gonzalez Macias. 1999. Endocarditis due to Acinetobacter lwoffi on native mitral valve. Int. J. Cardiol.69:97-99.

Valero, E., D. Sevillano, A. Calvo, R. Garcia, A. Leturia, and M. L. Gomez-Lus. 2001. Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii. Rev. Esp. Quimioter.14:358-363.

10.1111/j.1469-0691.2006.01510.x

10.1016/j.resmic.2003.10.003

10.1128/JCM.38.11.4280-4281.2000

10.1128/jcm.33.1.11-15.1995

10.1016/S0923-2508(99)80047-3

10.1128/AEM.72.1.932-936.2006

10.1111/j.1469-0691.2004.00942.x

10.1128/JCM.38.9.3523-3523.2000

10.1073/pnas.0507407103

Vidal, R., M. Dominguez, H. Urrutia, H. Bello, G. Gonzalez, A. Garcia, and R. Zemelman. 1996. Biofilm formation by Acinetobacter baumannii. Microbios86:49-58.

10.1128/AAC.37.1.138

10.1093/jac/dkl509

10.1093/jac/39.6.757

10.1128/AAC.39.5.1201

10.1128/JCM.37.3.758-761.1999

10.1086/502205

10.1128/AAC.00226-07

10.7326/0003-4819-129-3-199808010-00003

von Lingelsheim, W. 1908. Beitrage zur Epidemiologie der epidemischen Genickstarre nach den Ergebnissen der letzten Jahre. Z. Hyg. Infektkrankh.59:457-460.

10.1128/AAC.00210-06

10.1128/CMR.18.2.306-325.2005

Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, Z. Sun, E. Reed, L. Ding, J. Gong, Q. Q. Li, and J. Hu. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med.17:309-317.

10.1128/JCM.40.4.1526-1529.2002

10.1186/1476-0711-5-10

10.1056/NEJMp048093

10.1086/514545

Whitman, T. J. 2007. Infection control challenges related to war wound infections in the ICU setting. J. Trauma62:S53.

10.1093/clinids/24.3.494

10.1086/421946

Wisplinghoff H. C. Hippler S. G. Bartual C. Haefs D. Stefanik P. G. Higgins and H. Seifert. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a recently proposed MLST scheme. Clin. Microbiol. Infect. in press.

10.1086/314040

Wisplinghoff, H., W. Perbix, and H. Seifert. 1999. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients. Clin. Infect. Dis.28:59-66.

10.1016/j.jhin.2007.02.016

10.1128/AAC.43.6.1406

10.1086/340055

10.1016/j.ajic.2005.01.009

10.1016/j.jhin.2004.04.009

10.1111/j.1469-0691.2007.01694.x

Yamamoto, S., N. Okujo, and Y. Sakakibara. 1994. Isolation and structure elucidation of acinetobactin, a novel siderophore from Acinetobacter baumannii. Arch. Microbiol.162:249-254.

10.3201/eid1106.040924

10.1016/j.diagmicrobio.2004.01.002

10.1099/jmm.0.46117-0

10.1128/AAC.47.5.1749-1751.2003

10.1128/JCM.37.10.3108-3112.1999

10.1128/AAC.48.3.753-757.2004

10.1128/AAC.36.11.2566

10.1093/jac/dkf043

10.7205/MILMED.171.9.821

10.1111/j.1469-0691.2006.01675.x

10.1128/JCM.42.3.946-953.2004

10.1099/jmm.0.47206-0